Meningococcal carriage 7 years after introduction of a serogroup A meningococcal conjugate vaccine in Burkina Faso: results from four cross-sectional carriage surveys

BACKGROUND: In the first 2 years after a nationwide mass vaccination campaign of 1–29-year-olds with a meningococcal serogroup A conjugate vaccine (MenAfriVac) in Burkina Faso, carriage and disease due to serogroup A Neisseria meningitidis were nearly eliminated. We aimed to assess the long-term eff...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Lancet Infect Dis
Autors principals: Mbaeyi, Sarah, Sampo, Emmanuel, Dinanibè, Kambiré, Yaméogo, Issaka, Congo-Ouédraogo, Malika, Tamboura, Mamadou, Sawadogo, Guetawendé, Ouattara, Kalifa, Sanou, Mahamadou, Kiemtoré, Tanga, Dioma, Gerard, Sanon, Barnabé, Somlaré, Hermann, Kyetega, Augustin, Ba, Absatou Ky, Aké, Flavien, Tarbangdo, Félix, Aboua, Frederic Acho, Donnou, Yvette, Kamaté, Idrissa, Patel, Jaymin C, Schmink, Susanna, Spiller, Michael W, Topaz, Nadav, Novak, Ryan, Wang, Xin, Bicaba, Brice, Sangaré, Lassana, Ouédraogo-Traoré, Rasmata, Kristiansen, Paul A
Format: Artigo
Idioma:Inglês
Publicat: Elsevier Science ;, The Lancet Pub. Group 2020
Matèries:
Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7689286/
https://ncbi.nlm.nih.gov/pubmed/32653071
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S1473-3099(20)30239-5
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars